Results 201 to 210 of about 217,476 (395)

To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer

Annals of Gastroenterological Surgery, EarlyView.
NAT‐GS was significantly more effective only in patients with one tumor marker above the reference range, comparing those who achieved 12‐month MRFS with those who did not. ABSTRACT Aim Pancreatic cancer (PC) remains one of the most lethal malignancies, with early recurrence severely affecting prognosis even after curative resection.
Hiromichi Kawaida, Wataru Izumo, Ryo Saito, Hidetake Amemiya, Suguru Maruyama, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Yoshihiko Kawaguchi, Daisuke Ichikawa   +9 more
wiley   +1 more source

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

Surgery, 2012
C. Ferrone, R. Pieretti-Vanmarcke, Jordan P Bloom, Hui Zheng, Jackye Szymonifka, J. Wargo, S. Thayer, G. Lauwers, V. Deshpande, Mari Mino-Kenudson, C. F. Fernandez-Del Castillo, K. D. Lillemoe, A. Warshaw   +12 more
semanticscholar   +1 more source

Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

Animal Models and Experimental Medicine, EarlyView.
Adropin is related to the energy homeostasis‐associated gene. It significantly increased glutathione reductase enzyme levels in the pancreas of experimental diabetic rats. Adropin may reduce the severity of diabetes and its complications. Cell proliferation in the exocrine is reduced after the administration of adropin.
Ifrah I. Ali, Crystal D'Souza, Abderrahim Nemmar, Shreesh Ojha, Ernest A. Adeghate   +4 more
wiley   +1 more source

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. [PDF]

, 2019
Cancer cell lines are a cornerstone of cancer research but previous studies have shown that not all cell lines are equal in their ability to model primary tumors.
Aran, D, Butte, AJ, Charalel, J, Chen, B, Goldstein, T, Sirota, M, van 't Veer, LJ, Wolf, DM, Yau, C, Yu, K   +9 more
core   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

Evaluation and treatment decision of pancreatic tumors by use of MRI with MRCP imaging [PDF]

, 2009
Background: Pancreatic cancer is one of the most malignant tumors. Symptoms are usually nonspecific and insidious such that the cancer is advanced by the time of diagnosis.
Turowska, Aldona, Walecki, Jerzy, Łebkowska, Urszula   +2 more
core  

An Investigation of Hyperostosis Frontalis Interna in a Modern Anatomical Body Donor Population

Clinical Anatomy, EarlyView.
ABSTRACT This research sought to examine the prevalence and severity of hyperostosis frontalis interna (HFI) in the Chicagoland anatomical body donor population. The study further aimed to elucidate potential demographic risk factors for HFI, including sex, age at death, and structural vulnerability index (SVI), as well as any common comorbidities, as ...
Amy C. Beresheim, Amanda Hall
wiley   +1 more source

The INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNA

Cancer Communications, EarlyView.
Abstract Background Blood‐based cell‐free DNA (cfDNA) methylation testing has emerged as a promising approach for multi‐cancer early detection (MCED), holding the potential to improve cancer survival rates. However, traditional bisulfite‐based methods often encounter sensitivity limitations in detecting early‐stage malignancies or certain cancer types.
Hui‐Yan Luo, Wei Wei, Pansong Li, Qi‐Hua Zhang, Zhipeng Zhou, Liang Cui, Yong‐Bin Lin, Hong Yang, Xianyu Zhong, Qingfeng Liu, Han Yang, Kong‐Jia Luo, Hai‐Bo Qiu, Shu‐Qiang Yuan, Yuan‐Fang Li, Zhi‐Wei Zhou, Xiao‐Jun Lin, Bo‐Kang Cui, Rong‐Xin Zhang, Wen‐Hua Fan, He Huang, Chun‐Yan Lan, Jun‐Dong Li, Zhi‐Qiang Wang, Bin‐Kui Li, Rong‐Ping Guo, Jun Tang, Xin Huang, Mian Xi, Yuying Liu, Chuanbo Xie, Shi Chen, Zhi‐Hu Li, Yu‐Hua Liu, Xiao‐Ting Zhang, Qiang Zeng, Xin Yi, Rui‐Hua Xu   +37 more
wiley   +1 more source

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Cancer Cell, 2017
Benjamin J. Raphael, R. Hruban, A. Aguirre, R. Moffitt, J. Yeh, C. Stewart, A. G. Robertson, A. Cherniack, M. Gupta, G. Getz, S. Gabriel, M. Meyerson, C. Cibulskis, S. Fei, T. Hinoue, Hui Shen, P. Laird, Shiyun Ling, Yiling Lu, G. Mills, Rehan Akbani, Phillipe Loher, Eric Londin, I. Rigoutsos, Aristeidis G. Telonis, E. Gibb, A. Goldenberg, A. Mezlini, K. Hoadley, E. Collisson, E. Lander, Bradley A. Murray, J. Hess, Mara W Rosenberg, Louis Bergelson, Hailei Zhang, Juok Cho, G. Tiao, Jaegil Kim, D. Livitz, I. Leshchiner, B. Reardon, E. Allen, A. Kamburov, R. Beroukhim, G. Saksena, S. Schumacher, M. Noble, David I Heiman, Nils Gehlenborg, M. Lawrence, V. Adsay, G. Petersen, D. Klimstra, N. Bardeesy, Mark D. M. Leiserson, R. Bowlby, K. Kasaian, I. Birol, K. Mungall, S. Sadeghi, J. Weinstein, P. Spellman, Yuexin Liu, L. Amundadottir, J. Tepper, A. Singhi, R. Dhir, Drwiega Paul, T. Smyrk, Lizhi Zhang, Paula Kim, Jay Bowen, J. Frick, J. Gastier-Foster, M. Gerken, Kevin R Lau, K. Leraas, T. Lichtenberg, N. Ramirez, Jeremy Renkel, M. Sherman, L. Wise, P. Yena, E. Zmuda, J. Shih, Adrian Ally, M. Balasundaram, R. Carlsen, Andy Chu, E. Chuah, A. Clarke, Noreen Dhalla, R. Holt, Steven J. M. Jones, Darlene Lee, Yussanne Ma, M. Marra, Michael Mayo, Richard A. Moore, A. Mungall, J. Schein, Payal Sipahimalani, Angela Tam, N. Thiessen, Kane Tse, Tina Wong, Denise Brooks, J. Auman, S. Balu, T. Bodenheimer, D. Hayes, A. Hoyle, S. Jefferys, Corbin D. Jones, S. Meng, P. Mieczkowski, Lisle E. Mose, C. Perou, Amy H. Perou, J. Roach, Yan Shi, J. Simons, Tara J. Skelly, Matthew G. Soloway, Donghui Tan, Umadevi Veluvolu, J. Parker, M. Wilkerson, Anil Korkut, Y. Şenbabaoğlu, P. Burch, R. McWilliams, K. G. Chaffee, A. Oberg, Wei Zhang, M. Gingras, D. Wheeler, Liu Xi, Monique Albert, J. Bartlett, H. Sekhon, Y. Stephen, Zaren Howard, M. Judy, A. Breggia, R. Shroff, Sudha Chudamani, Jia Liu, Laxmi Lolla, R. Naresh, T. Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Smith Jennifer, K. Roggin, K. Becker, M. Behera, Joseph Bennett, L. Boice, E. Burks, C. G. C. Júnior, J. Chabot, D. Tirapelli, J. S. Santos, M. Dubina, J. Eschbacher, Meijuan Huang, L. Huelsenbeck-Dill, R. Jenkins, A. Karpov, R. Kemp, V. Lyadov, S. Maithel, G. Manikhas, E. Montgomery, H. Noushmehr, A. Osunkoya, T. Owonikoko, O. Paklina, O. Potapova, S. Ramalingam, W. Rathmell, K. Rieger-Christ, Charles Saller, G. Setdikova, A. Shabunin, G. Sica, T. Su, T. Sullivan, P. Swanson, Katherine Tarvin, M. Tavobilov, L. Thorne, S. Urbanski, Olga Voronina, Timothy C. Wang, D. Crain, Erin E. Curley, J. Gardner, D. Mallery, S. Morris, J. Paulauskis, R. Penny, C. Shelton, T. Shelton, K. Janssen, O. Bathe, N. Bahary, J. Slotta-Huspenina, A. Johns, H. Hibshoosh, R. Hwang, A. Sepulveda, Amie Radenbaugh, S. Baylin, Mario Berrios, Moiz Bootwalla, Andrea E Holbrook, Phillip H. Lai, D. Maglinte, S. Mahurkar, T. Triche, D. V. Berg, D. Weisenberger, L. Chin, R. Kucherlapati, M. Kucherlapati, A. Pantazi, P. Park, Douglas Voet, Pei Lin, S. Frazer, T. DeFreitas, S. Meier, S. Kwon, Y. Kim, Sang Jae Park, Sung-Sik Han, S. Kim, H. Kim, E. Furth, M. Tempero, C. Sander, A. Biankin, D. Chang, Peter Bailey, A. Gill, J. Kench, S. Grimmond, R. Postier, R. Zuna, H. Sicotte, John A. Demchok, M. Ferguson, C. Hutter, K. Shaw, Margi Sheth, H. Sofia, R. Tarnuzzer, Zhining Wang, Liming Yang, J. Zhang, Ina Felau, J. Zenklusen   +265 more
semanticscholar   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, EarlyView.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source